FGFRi are effective treatment strategies for patients with advanced solid tumors harboring FGFR alterations, with manageable toxicities in most patients. FGFRi are a safe and effective treatment ...
Phase II trial of camrelizumab plus apatinib in combination with stereotactic body radiotherapy (SBRT) in patients with recurrent/metastatic non–clear-cell renal cell carcinoma (nccRCC). This is an ...
This systematic literature review and pooled rates analysis investigated the standard of care for patients with heart failure in the US post hospital discharge. Results: There were 31 studies that met ...
WASHINGTON, DC—In women with symptomatic severe aortic stenosis (AS), TAVI yields better outcomes at 1 year compared with surgery, with no differences by annular size or age, according to a large ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results